4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-21-010477
President sold 30,000 shares at an average $63.12 ($1,893,554)
- President acquired 30,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| RUBINSTEIN JULIE President | 2021-02-10 | Option exercise | +15,000 | $6.55 | $98,250 | 15,000 | D: show line 1 in the form |
| RUBINSTEIN JULIE President | 2021-02-10 | Sale | −6,770 | $62.14 | $420,688 | 8,230 | D: show line 2 in the form |
| RUBINSTEIN JULIE President | 2021-02-10 | Sale | −3,814 | $63.00 | $240,282 | 4,416 | D: show line 3 in the form |
| RUBINSTEIN JULIE President | 2021-02-10 | Sale | −3,798 | $64.09 | $243,414 | 618 | D: show line 4 in the form |
| RUBINSTEIN JULIE President | 2021-02-10 | Sale | −618 | $64.76 | $40,022 | 0 | D: show line 5 in the form |
| RUBINSTEIN JULIE President | 2021-02-11 | Option exercise | +15,000 | $6.55 | $98,250 | 15,000 | D: show line 6 in the form |
| RUBINSTEIN JULIE President | 2021-02-11 | Sale | −10,729 | $63.12 | $677,214 | 4,271 | D: show line 7 in the form |
| RUBINSTEIN JULIE President | 2021-02-11 | Sale | −4,271 | $63.67 | $271,935 | 0 | D: show line 8 in the form |
| Open-market sales · 30,000 sh · avg $63.12 · $1,893,554 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| RUBINSTEIN JULIE President | 2021-02-10 | Option exercise · Stock Option (Right to Buy) | −15,000 | 375,000 | D: show line 9 in the form | ||
| RUBINSTEIN JULIE President | 2021-02-11 | Option exercise · Stock Option (Right to Buy) | −15,000 | 360,000 | D: show line 10 in the form |
Loading xslF345X03/doc4.xml…